Abstract
Robust and effective T cell immune surveillance and cancer immunotherapy require proper allocation of metabolic resources to sustain energetically costly processes, including growth and cytokine production. Here, we show that asparagine (Asn) restriction on CD8+ T cells exerted opposing effects during activation (early phase) and differentiation (late phase) following T cell activation. Asn restriction suppressed activation and cell cycle entry in the early phase while rapidly engaging the nuclear factor erythroid 2-related factor 2 (NRF2)-dependent stress response, conferring robust proliferation and effector function on CD8+ T cells during differentiation. Mechanistically, NRF2 activation in CD8+ T cells conferred by Asn restriction rewired the metabolic program by reducing the overall glucose and glutamine consumption but increasing intracellular nucleotides to promote proliferation. Accordingly, Asn restriction or NRF2 activation potentiated the T cell-mediated antitumoral response in preclinical animal models, suggesting that Asn restriction is a promising and clinically relevant strategy to enhance cancer immunotherapy. Our study revealed Asn as a critical metabolic node in directing the stress signaling to shape T cell metabolic fitness and effector functions.
Original language | English |
---|---|
Pages (from-to) | 1423-1439 |
Number of pages | 17 |
Journal | Nature Metabolism |
Volume | 5 |
Issue number | 8 |
DOIs | |
State | Published - Aug 2023 |
Bibliographical note
Publisher Copyright:© 2023, The Author(s).
Funding
We thank X. Song, N. Restifo and W. Terence for their reagents and advice. This work was supported by 1UO1CA232488-01, 2R01AI114581-06, R01CA247941 and 1R01AI175004-01 from the National Institutes of Health (NIH); V2014-001 from the V Foundation; and 128436-RSG-15-180-01-LIB from the American Cancer Society (to R.W.); as well as the T32 Ruth L. Kirschstein National Research Service Award CA269052 from the NIH (to S.K.). The Sanford Burnham Prebys (SBP) Cancer Metabolism Core was supported by the SBP National Cancer Institute (NCI) Cancer Center Support Grant P30 CA030199 (to D.A.S.). The Center for Environmental and Systems Biochemistry Core was partly supported by the Markey Cancer Center support grant P30CA177558 (to T.W.-M.F.).
Funders | Funder number |
---|---|
National Institutes of Health (NIH) | V2014-001 |
National Institutes of Health (NIH) | |
American Cancer Society-Michigan Cancer Research Fund | CA269052 |
American Cancer Society-Michigan Cancer Research Fund | |
National Childhood Cancer Registry – National Cancer Institute | P30 CA030199 |
National Childhood Cancer Registry – National Cancer Institute | |
V Foundation for Cancer Research | 128436-RSG-15-180-01-LIB |
V Foundation for Cancer Research | |
University of Kentucky Markey Cancer Center | P30CA177558 |
University of Kentucky Markey Cancer Center |
ASJC Scopus subject areas
- Internal Medicine
- Endocrinology, Diabetes and Metabolism
- Physiology (medical)
- Cell Biology